Diagnosis and Emerging Biomarkers of Cystic Fibrosis-Related Kidney Disease (CFKD)
Authors:
- Hayrettin YavuzHYHayrettin Yavuz
- Manish KumarMKManish Kumar
- Himanshu Ballav GoswamiHGHimanshu Ballav Goswami
- Uta ErdbrüggerUEUta Erdbrügger
- William Tom HarrisWHWilliam Tom Harris
- Sladjana Skopelja-GardnerSSSladjana Skopelja-Gardner
- Martha GraberMGMartha Graber
- Agnieszka Swiatecka-UrbanASAgnieszka Swiatecka-Urban
Preprint
- 24 June 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
As people with cystic fibrosis (PwCF) live longer, kidney disease is emerging as a sig-nificant comorbidity that increasingly is linked to cardiovascular complications and progression to end-stage kidney disease. In our recent review, we proposed the unifying term CF-related kidney disease (CFKD) to encompass the spectrum of kidney dysfunction observed in this population. Early detection of kidney injury is critical for improving long-term outcomes yet remains challenging due to the limited sensitivity of conventional laboratory tests, particularly in individuals with altered muscle mass and unique CF pathophysiology. Emerging approaches, including novel blood and urinary biomarkers, urinary ex-tra-cellular vesicles, and genetic risk profiling, offer promising avenues for identifying subclinical kidney damage. When integrated with machine learning algorithms, these tools may enable the development of personalized risk stratification models and targeted therapeutic strategies. This precision medicine approach has the potential to transform kidney disease man-agement in PwCF, shifting care from reactive treatment of late-stage disease to proactive monitoring and early intervention.Keywords
All Related Versions
- Version 1, 2025-06-24, Preprints
- Published version: Journal of Clinical Medicine, 14 (15), 5585.
This publication has 141 references indexed in Scilit:
- Cystic fibrosis–related kidney disease—emerging morbidity and disease modifierPediatric Nephrology, 2025
- A review of cystic fibrosis: Basic and clinical aspectsAnimal Models and Experimental Medicine, 2021
- Current knowledge on exosome biogenesis and releaseCellular and Molecular Life Sciences, 2017
- Biomarkers for Kidney Injury in Cystic Fibrosis2016
- Tubulointerstitial nephritis: diagnosis, treatment, and monitoringPediatric Nephrology, 2016
- Isoforms of wild type proteins often appear as low molecular weight bands on SDS‐PAGEBiotechnology Journal, 2014
- Electrolyte abnormalities in cystic fibrosis: systematic review of the literaturePediatric Nephrology, 2013
- NO pathway in CF and non‐CF childrenPediatric Pulmonology, 2004
- Nasal Nitric Oxide Levels in Cystic Fibrosis Patients Are Associated with a Neuronal NO Synthase (NOS1) Gene PolymorphismNitric Oxide, 2002
- Allotypes of α1‐antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508Pediatric Pulmonology, 1994